Investigating how certain drugs may affect Alzheimer's disease outcomes.
Analysis of Alzheimer's disease studies that feature truncated or interval-censored covariates
This study is looking at how certain medications might help people with Alzheimer's by improving the way we analyze past research, so we can get better answers about their effects.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-10901990 on NIH RePORTER |
What this research studies
This research focuses on understanding the effects of drug exposure on Alzheimer's disease by analyzing existing studies that have not fully accounted for certain data limitations. The researchers aim to develop new methods to address issues like incomplete data and measurement errors, which can lead to biased results. By applying these methods to specific case studies, they hope to provide clearer insights into how repurposed drugs might help reduce the risk of Alzheimer's or slow its progression. This work is crucial as it seeks to improve the understanding of treatment effects in a complex disease like Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those already diagnosed with Alzheimer's or related dementias.
Not a fit: Patients with non-Alzheimer's related forms of dementia or those not at risk for Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for Alzheimer's disease, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promise in repurposing drugs for Alzheimer's treatment, but this approach of addressing data limitations is relatively novel.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Qian, Jing — University of Massachusetts Amherst
- Study coordinator: Qian, Jing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.